Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2023
Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective studyAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.Journal of Experimental & Clinical Cancer Research : CR|July 18, 2025
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanomaAndrea Anichini, Francesca P Caruso, Vincenzo Lagano, et al.International Journal of Cancer|November 16, 2012
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytesVincenzo Russo, Lorenzo Pilla, Francesca Lunghi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2020
Systemic Therapy for Melanoma: ASCO GuidelineRahul Seth, Hans Messersmith, Varinder Kaur, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic TumorsAndrea Maurichi, Rosalba Miceli, Roberto Patuzzo, et al.British Journal of Cancer|October 22, 2020
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysisPrachi Bhave, Lalit Pallan, Georgina V Long, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2023
Systemic Therapy for Melanoma: ASCO Guideline UpdateRahul Seth, Sanjiv S Agarwala, Hans Messersmith, et al.The Lancet. Oncology|June 18, 2018
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trialBrigitte Dreno, John F Thompson, Bernard Mark Smithers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive NomogramAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.Journal for Immunotherapy of Cancer|July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanomaPrachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.Pageof 11